Study guide
7.2 Long-Bone Fractures and Fat Embolism
ABIM Neurocritical Care Subspecialty Certification Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Practice Pathway, and the IM Training Route 1.3 Format, Scoring, Pearson VUE, and Score Reports 1.4 How to Use This Independent Study Guide
2 ICU Neurologic Exam, Cerebral Physiology, and CSF
2.1 Neurological Examination in the ICU 2.2 Cerebral Physiology, ICP, CBF, and Autoregulation 2.3 CSF Physiology
3 Core Neuropharmacology
3.1 Osmotic Agents 3.2 Anti-Seizure Drugs 3.3 Anesthetics, Sedatives, Analgesia, and Paralytics 3.4 Antihypertensives, Vasopressors, and Inotropes
4 Reperfusion Drugs, Airway, and Ventilation
4.1 Thrombolytics, Anticoagulants, and Antiplatelets 4.2 Reversal of Anticoagulation After Acute Hemorrhage 4.3 Airway Management and Tracheostomy 4.4 Mechanical Ventilation
5 Hemodynamics and Shock
5.1 Hemodynamic Monitoring 5.2 IABP, Temporary VADs, LVAD, and ECMO 5.3 Diagnosis and Management of Shock
6 Nutrition, Temperature, and ICU Prophylaxis
6.1 Nutrition (01.J) 6.2 Temperature Control (01.K) 6.3 ICU Prophylaxis, Delirium, and Early Mobility (01.L)
7 General Trauma
7.1 Emergency Evaluation of Polytrauma, Chest, and Abdominal Trauma 7.2 Long-Bone Fractures and Fat Embolism 7.3 Burns, Electrical Injury, and Hanging/Strangulation
8 Pulmonary Critical Care
8.1 Pulmonary Physiology and ARDS (01.N.1–2) 8.2 PE, Pneumonia, and Pulmonary Edema (01.N.3, 7–8) 8.3 COPD, Asthma, PAH, and Bronchoscopy Basics (01.N.4–6, 9)
9 Cardiovascular Critical Care
9.1 Cardiovascular Physiology, Stress Cardiomyopathy, ACS, and Valves 9.2 Arrhythmias and Pacing 9.3 Acute Aortic Dissection and Cardiac Ultrasound
10 Renal and Infectious Disease
10.1 AKI, RRT, and Renal Drug Dosing 10.2 Acid-Base and Electrolyte Disorders 10.3 Severe Sepsis, Septic Shock, and Infective Endocarditis 10.4 Antimicrobial Use and Infection in the Immunosuppressed
11 Endocrine and Salt-Water Disorders
11.1 Pituitary Apoplexy, DI, and Panhypopituitarism (01.R.1–4) 11.2 SIADH and Cerebral Salt Wasting (01.R.5–6) 11.3 Thyrotoxicosis, Myxedema, Adrenal Crisis, and Dysglycemia (01.R.7–9)
12 Gastrointestinal Critical Care
12.1 GI Physiology, Acute Abdomen, Bleed, Ileus, and Perforation (01.S.1–5) 12.2 Mesenteric Ischemia and Abdominal Compartment Syndrome (01.S.6–7) 12.3 Fulminant Liver Failure, Cirrhosis Decompensation, and Hepatic Dosing (01.S.8–10)
13 Hematologic Disorders
13.1 Anemia, Transfusion, Thrombocytopenia, Coagulopathy, and DIC (01.T.1–4) 13.2 VTE in the Neuro ICU (01.T.5) 13.3 Chemo/Immune, SCT, CAR-T, Sickle Cell, and TMA (01.T.6–10)
14 Neuroimaging
14.1 CT of Brain and Spine 14.2 MRI and CT/MR Perfusion 14.3 Noninvasive Angiography and Catheter Angiography
15 EEG, EMG, and CSF Analysis
15.1 EEG, Standard and Processed (02.B) 15.2 Basic EMG Interpretation (02.G) 15.3 CSF Analysis (02.H)
16 ICP, TCD, and Multimodality Monitoring
16.1 ICP Monitoring (02.C) 16.2 Transcranial Doppler (02.D) 16.3 Brain-Tissue Oxygen and Multimodality Monitoring (02.E–F)
17 Brain Death and Bedside Procedures
17.1 Brain Death Prerequisites and Clinical Exam (02.I) 17.2 Apnea Testing and Ancillary Studies (02.I) 17.3 Vascular Access, Thoracic Echo, and Lung Ultrasound (02.J–L)
18 Coma, Anoxia, and Intracranial Hypertension
18.1 Coma and Other States of Altered Consciousness (03.A) 18.2 Global Anoxia-Ischemia and Post-Resuscitation Encephalopathy (03.A.1) 18.3 Toxidromes, ICU Delirium, and Hypertensive Encephalopathy (03.A.2–4) 18.4 Intracranial Hypertension as a Disease State (03.B)
19 Acute Ischemic Stroke
19.1 IV Reperfusion Therapy (03.C.3) 19.2 Mechanical Thrombectomy Windows and Imaging Selection (03.C.3) 19.3 Malignant Hemispheric Infarction and Basilar Artery Occlusion (03.C.1–2)
20 Intraparenchymal Hemorrhage
20.1 Intracerebral Hematoma (03.D.1) 20.2 Cerebellar Hematoma (03.D.2) 20.3 Intraventricular Hemorrhage (03.D.3)
21 SAH, CVST, and Spinal Cord Infarction
21.1 Aneurysmal Subarachnoid Hemorrhage (03.E.1) 21.2 Non-Aneurysmal SAH (03.E.2) 21.3 Cerebral Venous Sinus Thrombosis (03.F) 21.4 Spinal Cord Infarction (03.G)
22 Vascular Anomalies and Traumatic Brain Injury
22.1 Unruptured Aneurysm, Cavernoma, AVM, and Dural AVF (03.H) 22.2 Diffuse Axonal Injury and Cerebral Contusions (03.I.1–2) 22.3 Epidural Hematoma, Subdural Hematoma, and Penetrating Injury (03.I.3–4, 7) 22.4 Arterial Dissection and Carotid-Cavernous Fistula (03.I.5–6)
23 Spine, Hydrocephalus, and CNS Infection
23.1 Spinal Cord Injury, Central Cord, and Neurogenic Shock (03.J) 23.2 Unstable Spine Fractures (03.K) 23.3 Hydrocephalus and CSF Diversion (03.L) 23.4 Acute CNS Infections (03.M)
24 Seizures and Neuromuscular Emergencies
24.1 Status Epilepticus and Seizures (03.N) 24.2 Guillain-Barré Syndrome (03.O.1) 24.3 Myasthenic Crisis (03.O.2) 24.4 Motor Neuron Disease, Acute Myopathies, Rhabdomyolysis, and CINM (03.O.3–6)
25 Inflammatory Disease, Neuro-Oncology, and Special Populations
25.1 Fulminant Demyelinating Diseases (03.P) 25.2 Autoimmune Encephalitis and Acute Autonomic Hyperactivity (03.Q–R) 25.3 Neuro-Oncology and Treatment Complications (03.S) 25.4 Pregnancy/Post-Partum, Post-Transplant, and Pediatric Patients (03.T–U)
26 Neurosurgical and Perioperative Complications
26.1 Postoperative Seizures, Hemorrhage, Ischemia, and Hyperperfusion (04.A, C, D, H) 26.2 Infection, CSF Leak, and Pneumocephalus (04.B, E, F) 26.3 Complications of EVD and Lumbar Drain (04.G, I)
27 Ethics, Prognostication, and Organ Donation
27.1 Communication, Decision-Makers, Advance Directives, and DNR (05.A, B, G) 27.2 Uncertainties of Prognostication and the Self-Fulfilling Prophecy (05.C) 27.3 Palliative Care, Withdrawal, Withholding, and Futility (05.D–F) 27.4 Donation After Cardiac Death and Care of the Organ Donor (05.H–I)
7.2 Long-Bone Fractures and Fat Embolism
Key Takeaways Explain This Topic AI
Uncontrolled ICP, ongoing shock, severe acidosis, hypothermia, or coagulopathy are reasons for damage-control orthopedics (external fixation or traction), not same-night reamed nailing.
Fat embolism syndrome typically appears 24–72 hours after long-bone or pelvic injury with hypoxemia, neurologic change, and sometimes an axillary or conjunctival petechial rash.
Gurd criteria are a clinical frame: major features are respiratory insufficiency, cerebral involvement unexplained by head injury, and petechial rash; diagnosis is often taught as one major plus four minor features.
Treatment is supportive oxygenation, ventilation, and neurocritical care. Heparin is not primary therapy for fat embolism syndrome.
Early immobilization and timely definitive fixation in a resuscitated patient reduce fat-embolism risk; MRI may show a cerebral starfield pattern when the brain is involved.
Last updated: September 2026
Long-bone and pelvic fractures are both a hemorrhage problem and a delayed embolic–inflammatory problem. The neurointensivist’s job is to decide when a femur may be nailed without wrecking intracranial pressure (ICP), and to recognize fat embolism syndrome (FES) when hypoxemia and unexplained neurologic change appear a day or two later. Fat globules enter the venous circulation from marrow after shaft fractures and after instrumentation; most patients have subclinical emboli. The exam tests whether you can separate that physiology from thromboembolic pulmonary embolism and from the primary head injury.
Timing of Fixation Versus Unstable ICP
Early total care —definitive intramedullary nailing of a femur in the first day—reduces pulmonary complications and FES risk in a resuscitated patient. It is the wrong operation in a patient with uncontrolled intracranial hypertension, evolving herniation, uncorrected shock, severe acidosis, hypothermia, or coagulopathy. Those patients receive damage-control orthopedics : spanning external fixation, traction, or splinting to stop ongoing marrow embolization from an unstable shaft, followed by delayed conversion when physiology allows.
A practical exam vignette is a patient with a femoral shaft fracture, ICP 28 mm Hg despite osmotherapy, and a fresh external ventricular drain. That patient is not a candidate for reaming and nailing tonight. Place an external fixator in the intensive care unit or operating room, continue ICP-directed care, then schedule nailing when ICP is controlled, CPP is stable, transfusion requirement has slowed, and lactate has cleared. Early appropriate care is the modern phrase: fix when resuscitation endpoints are met, not because a clock struck 24 hours. An unstable pelvis is analogous: binder, packing or angioembolization, then staged reconstruction.
Intramedullary reaming raises embolic load. If nailing must proceed in a tenuous neuro patient, the surgeon should minimize reaming and operative time, and the intensivist should treat the case as an ICP-crisis rehearsal: head of bed, osmotherapy drawn, PaCO2 in a safe range, and blood pressure guaranteed. Do not “make room” for nailing by driving PaCO2 below 25 mm Hg as a planned strategy.
Physiology Fixation strategy Why
Controlled ICP, stable shock labs, warming, clotting Early appropriate definitive fixation (often nailing) Lowers FES and pulmonary-failure risk
ICP crisis, herniation, or an untreated mass lesion Delay nailing; external fix or traction Reaming and hypotension wreck CPP
Acidosis, hypothermia, coagulopathy, ongoing MTP Damage-control orthopedics Lethal diamond plus marrow emboli
Isolated femur, resuscitated, reliable neurologic exam Time-appropriate nailing Prevention of FES is timely immobilization
Fat Embolism Syndrome: Timing and Triad
FES is a clinical syndrome, not a CT-angiogram diagnosis of clot. Mechanical obstruction of pulmonary and cerebral capillaries is followed by a delayed inflammatory injury as lipase generates free fatty acids. That is why the textbook presentation is not at the roadside . Typical onset is 24–72 hours after long-bone (especially femur or tibia) or pelvic injury, or after orthopedic instrumentation. Fulminant right-ventricular failure can appear earlier, but the exam favorite is the delayed triad after a femur is fixed—or left unfixed.
Classic features:
Acute hypoxemia or respiratory distress, often with a chest radiograph that looks like the acute respiratory distress syndrome or is still deceptively clear.
Neurologic change —agitation, delirium, seizure, focal deficit, or coma—out of proportion to the head CT.
Petechial rash over the axillae, conjunctivae, and upper trunk. The rash is present in a minority of cases but is highly specific when seen.
Other supportive findings include fever, tachycardia, thrombocytopenia, unexplained anemia, retinal cotton-wool or fat emboli, jaundice, and renal abnormalities. Cerebral FES on magnetic resonance imaging often shows a starfield pattern : innumerable punctate diffusion-restricting white-matter lesions. Head CT may be normal early. Bronchoalveolar lavage fat-laden macrophages can support the diagnosis; they are not required.
Distinguish cerebral FES from diffuse axonal injury . Diffuse axonal injury is an immediate shear injury from the original mechanism. FES is delayed, often after a lucid or relatively stable interval, and is accompanied by pulmonary and cutaneous clues. Also distinguish FES from thromboembolic pulmonary embolism, which more often appears later (days to weeks), lacks petechiae, and shows clot on CT pulmonary angiography.
Gurd Criteria, Conceptually
Gurd and Wilson’s criteria are a clinical scoring system, not a laboratory gold standard. You do not need to recite every minor bullet on test day, but you must know the architecture.
Major criteria:
- Petechial rash
- Respiratory insufficiency (hypoxemia, radiographic change)
- Cerebral involvement unexplained by head trauma or another cause
Minor criteria (examples): tachycardia (often taught as heart rate >110), fever (often >38.5 °C), retinal changes, jaundice, renal signs, anemia, thrombocytopenia, elevated erythrocyte sedimentation rate, and fat macroglobulinemia.
Diagnosis is typically framed as one major plus four minor criteria; some references also accept two major criteria. Schonfeld and Lindeque scores exist, but Gurd is the conceptual system this outline expects. FES remains a diagnosis of pattern recognition after you have thought about pneumonia, pulmonary embolism, delayed intracranial hematoma, fat-poor transfusion reactions, and occult abdominal sepsis.
Supportive Care, Not Heparin as Primary Therapy
There is no disease-specific antidote. Treat hypoxemia with oxygen and lung-protective ventilation. Support the right ventricle if pulmonary vascular obstruction is severe. Manage ICP and seizures as you would in any acute brain injury. Keep the patient euvolemic; some clinicians favor albumin because it binds free fatty acids, but that is adjunctive reasoning, not a proven cure.
Heparin is not first-line therapy for FES. Experimental lipase activation and free-fatty-acid release, plus bleeding risk in trauma, make routine anticoagulation inappropriate. Corticosteroids are not standard outside rare refractory discussions. An inferior vena cava filter does not catch fat. What does prevent FES is early immobilization and timely definitive fixation once the brain and shock physiology allow it.
If CT pulmonary angiography is negative, the timing is 24–72 hours, and axillary petechiae are present, do not start a heparin drip “for PE anyway.” You will not treat FES and you may bleed a fresh solid-organ or intracranial injury. If imaging instead shows a large pulmonary embolus in a later window without the FES triad, that is thromboembolism and is treated as such—the point is not that heparin is never used in trauma patients, but that heparin is not the primary therapy for FES.
Cerebral FES can raise ICP; treat the numbers, not the label. Prognosis is often better than the MRI appearance suggests if oxygenation and CPP are protected through the inflammatory window.